Minimally invasive fetoscopic repair of MMC for spinal dysraphism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 May 2019: Trial registered, NCT03936322

The trials

NCT03936322: Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study

State
Completed
Phase
No phase
People
3 taking part
Started
7 May 2019
Primary completion
30 Jun 2024
Arms
Pregnant women diagnosed with fetal myelomeningocele
Results
Posted on the registry
  1. 3 May 2019: Trial registered
  2. 7 May 2019: Trial started
  3. 30 Jun 2024: Trial completed
  4. 24 Feb 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.